Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:VIVE

Viveve Medical Q3 2022 Earnings Results & Report

Viveve Medical logo
$0.0002 0.00 (0.00%)
As of 10/22/2026 09:37 AM Eastern

Viveve Medical reported Q3 2022 earnings on November 10, 2022. The company reported EPS of -$0.59, while revenue was $1.68 million.

Research:Profile

Earnings Announcement Details

Quarter
Q3 2022
Report Date

Viveve Medical EPS Results

Actual EPS
-$0.59
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
6 of last 8 quarters

Viveve Medical Revenue Results

Actual Revenue
$1.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Viveve Medical's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules.

Conference Call Resources

Viveve Medical Q3 2022 Earnings FAQ

Viveve Medical (NASDAQ:VIVE) reported earnings of -$0.59 per share for Q3 2022. The report was announced on Thursday, November 10, 2022.

Viveve Medical reported revenue of $1.68 million for Q3 2022.

Viveve Medical's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Viveve Medical on the company's earnings history page.

Viveve Medical Earnings Headlines

Viveve Medical Inc.
August 22, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/VIVE/financials/cash-flow
Viveve Medical Inc (VIVE)
July 24, 2024  |  investing.comhttps://www.investing.com/equities/p-l-c-systems-inc-news
$29.97 or $0 today
The 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightforward 3-step approach to trading same-day options, with entry, exit and max loss set before you ever place a trade. Plain English, no complicated math, done by market close. The price may return to 29.97 as soon as tomorrow.tc pixel
 |  Profits Run (Ad)
Incontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
July 19, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/incontinence-devices-pipeline-research-report-134200694.html
Vaginal Rejuvenation Is Big Business
July 19, 2024  |  ca.style.yahoo.comhttps://ca.style.yahoo.com/vaginal-rejuvenation-rise-results-often-155720347.html
VIVE Viveve Medical, Inc.
July 29, 2023  |  seekingalpha.comhttps://seekingalpha.com/symbol/VIVE
See More Viveve Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Viveve Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viveve Medical and other key companies, straight to your email.

About Viveve Medical

Viveve Medical (NASDAQ:VIVE) was a women’s health company focused on developing and commercializing noninvasive treatments for vaginal health. Its principal product was the Viveve System, a medical device that used cryogen-cooled monopolar radiofrequency energy to heat and remodel tissue. The company promoted the system primarily for the treatment of vaginal laxity and related intimate-health concerns.

The Viveve System was designed for use by healthcare professionals in office-based procedures and incorporated a disposable treatment tip. Viveve Medical sought regulatory clearances and commercial adoption in the United States and international markets, with distribution and clinical use reported in multiple countries.

The company operated under the name Viveve, Inc. before adopting the Viveve Medical name. Publicly available information about its later operations, leadership, and current commercial activities is limited, and the company’s status and product availability may have changed since its period of public trading under the symbol VIVE.

View Viveve Medical Profile
Earnings Tools